Search Results
Displaying results 61 - 80 of 133
- Publicationentity:bibcite_reference189,356,640
- Publicationentity:bibcite_reference192,381,536
- Publicationentity:bibcite_reference191,073,408
- Publicationentity:bibcite_reference217,517,952
- Publicationentity:bibcite_reference191,073,408
- Publicationentity:bibcite_reference191,507,472
- Publicationentity:bibcite_reference186,425,376
- Publicationentity:bibcite_reference183,583,488
- Publicationentity:bibcite_reference184,790,768
- Publicationentity:bibcite_reference191,073,408
- Publicationentity:bibcite_reference188,089,184
- Publicationentity:bibcite_reference189,782,944
- Publicationentity:bibcite_reference184,790,768
- Publicationentity:bibcite_reference189,782,944
- Professor Carol Hodgson is Head of the Division of Clinical Trials and Cohort Studies in the School of Public Health and Preventive Medicine, and Deputy Director of the Australian and New Zealand…entity:user2.4184573
- Beta-lactam antibiotics are commonly used to treat life-threatening infections in critically ill patients. As a class of antibiotics, beta-lactams are known as time-dependent antibiotics because they…10/4/2013 -Projectentity:node3.0258164
- The Point Prevalence Program (PPP) is a collaborative project between Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) and the Critical Care Division of The George…11/4/2013 -Projectentity:node3.0463848
- Sepsis is the most common cause of death in critically ill patients, with a quarter of those who develop severe sepsis dying during their hospitalisation. While many patients are admitted to hospital…11/4/2013 -Projectentity:node3.8507273
- Severe sepsis is an important cause of serious morbidity and mortality in New Zealand. The adult population incidence of severe sepsis is 0.77 per 1000 population per year with a 28-day mortality of…12/4/2013 -Projectentity:node175,476,736
- The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee has recommended the suspension of marketing of intravenous resuscitation fluids containing hydroxyethyl starch (HES…26/6/2013 -Newsentity:node3.067235